PROXY STATEMENT

Company

TherapeuticsMD, Inc.

Filed

November 29, 2004

Period of Report

December 3, 2004

Accession Number

0000025743-04-000023

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →